Illinois Cancer Specialists

Industry News

Tumor-Fighting Protein Stimulated By Compound Aids Cancer Therapy

Feb 10, 2013

A compound that stimulates the production of a tumor-fighting protein may improve the usefulness of the protein in cancer therapy, according to a team of researchers. TRAIL is a natural anti-tumor protein that suppresses tumor development during immune surveillance -- the immune system's process of patrolling the body for cancer cells... Read More

Lymphoma Cells Selectively Destroyed By Experimental Drug Combination

Feb 09, 2013

Laboratory experiments conducted by scientists at Virginia Commonwealth University Massey Cancer Center suggest that a novel combination of the drugs ibrutinib and bortezomib could potentially be an effective new therapy for several forms of blood cancer, including diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL)... Read More

New Approach Mimicking The Body's Natural Defenses Could Help Treat A Therapy-Resistant Breast Cancer

Feb 09, 2013

Cancer drugs of the new, molecular generation destroy malignant breast tumors in a targeted manner: They block characteristic molecules on tumor cells - receptors for the hormones estrogen or progesterone, or a co-receptor, called HER2, that binds to many growth factors. But about one in every six breast tumors has none of these receptors... Read More

Lymphoma Cells Selectively Destroyed By Experimental Drug Combination

Feb 09, 2013

Stress At Work Very Unlikely To Cause Cancer

Feb 08, 2013

But can cause other contributing factors Work-related stress is not linked to the development of colorectal, lung, breast or prostate cancers, a study published today on bmj.com suggests. Around 90% of cancers are linked to environmental exposures and whilst some exposures are well recognised (such as UV radiation and tobacco smoke), others are not (psychological factors such as stress)... Read More

ZALTRAP® (Aflibercept) Approved In The EU For Patients With Previously Treated Metastatic Colorectal Cancer

Feb 08, 2013

First and only agent to statistically significantly improve survival in combination with FOLFIRI chemotherapy after an oxaliplatin regimenSanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc... Read More

Sunlight Reduces The Risk Of Esophageal Cancer

Feb 08, 2013

Exposure to sunlight and UV is generally considered to be a risk factor for most forms of cancer, especially skin cancer. However a new study by Australian scientists shows that this general assumption is in fact unfounded. The successful treatment and cure of esophageal cancer depends on several factors... Read More

ZALTRAP® (Aflibercept) Approved In The EU For Patients With Previously Treated Metastatic Colorectal Cancer

Feb 08, 2013

In Lung Cancer, RNA Promotes Metastasis

Feb 08, 2013

The vast majority - approximately 80 percent - of our DNA does not code for proteins, yet it gets transcribed into RNA. These RNA molecules are called non-coding and fulfill multiple tasks in the cell. Alongside a well-studied group of small RNAs, there is also a class of so-called long non-coding RNAs consisting of more than 200 nucleotides... Read More

How Chromosomes Keep Their Loose Ends Loose Has Implications For Cancer And The Aging Process

Feb 08, 2013

We take it for granted that our chromosomes won't stick together, yet this kind of cellular disaster would happen constantly were it not for a protein called TRF2. Now, scientists at The Scripps Research Institute (TSRI) have discovered key details of how TRF2 performs this crucial chromosome-protecting function... Read More

Previous Page Next Page